Current knowledge of transient hypothyroxinemia of prematurity: to treat or not to treat?

References

• Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis. 2010;5:17.
   PubMed Web of Science ®Google Scholar
• Srinivasan G. Thyroid disorders. In: Gomella TL, Cunningham MD, Eyal FG, et al., editors. Neonatology: management, procedures, On-call Problems, Diseases and Drugs. 5th ed. New York: McGraw-Hill Medical; 2003. p. 585–589.
   Google Scholar
• Uhrmann S, Marks KH, Maisels MJ, et al. Thyroid function in the preterm infant: a longitudinal assessment. J Pediatr. 1978;92(6):968–973.
   PubMed Web of Science ®Google Scholar
• Adams LM, Emery JR, Clark SJ, et al. Reference ranges for newer thyroid function tests in premature infants. J Pediatr. 1995;126(1):122–127.
   PubMed Web of Science ®Google Scholar
• Fisher DA. Thyroid system immaturities in very low birth weight premature infants. Semin Perinatol. 2008;32(6):387–397.
   PubMed Web of Science ®Google Scholar
• Den Ouden AL, Kok JH, Verkerk PH, et al. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatr Res. 1996;39(1):142–145.
   PubMed Web of Science ®Google Scholar
• Reuss ML, Paneth N, Pinto-Martin JA, et al. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med. 1996;334(13):821–827.
   PubMed Web of Science ®Google Scholar
• van Wassenaer AG, Briët JM, van Baar A, et al. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants. Pediatrics. 2002;110(3):534–539.
   PubMed Web of Science ®Google Scholar
• Lucas A, Morley R, Fewtrell MS. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up. BMJ. 1996;312(7039):1132–3; discussion 1133.
   PubMed Web of Science ®Google Scholar
• Meijer WJ, Verloove-Vanhorick SP, Brand R, et al. Transient hypothyroxinaemia associated with developmental delay in very preterm infants. Arch Dis Child. 1992;67(7):944–947.
   PubMed Web of Science ®Google Scholar
• Simic N, Asztalos EV, Rovet J. Impact of neonatal thyroid hormone insufficiency and medical morbidity on infant neurodevelopment and attention following preterm birth. Thyroid. 2009;19(4):395–401.
   PubMed Web of Science ®Google Scholar
• Delahunty C, Falconer S, Hume R, et al. Levels of neonatal thyroid hormone in preterm infants and neurodevelopmental outcome at 5 1/2 years: millennium cohort study. J Clin Endocrinol Metab. 2010;95(11):4898–4908.
   PubMed Web of Science ®Google Scholar
• Ares S, Quero J, Diez J, et al. Neurodevelopment of preterm infants born at 28 to 36 weeks of gestational age: the role of hypothyroxinemia and long-term outcome at 4 years. J Pediatr Endocrinol Metab. 2011;24(11–12):897–902.
   PubMed Web of Science ®Google Scholar
• van Wassenaer AG, Kok JH. Trials with thyroid hormone in preterm infants: clinical and neurodevelopmental effects. Semin Perinatol. 2008;32(6):423–430.
   PubMed Web of Science ®Google Scholar
• Kester MH, Martinez de Mena R, Obregon MJ, et al. Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab. 2004;89(7):3117–3128.
   PubMed Web of Science ®Google Scholar
• Fisher DA, Nelson JC, Carlton EI, et al. Maturation of human hypothalamic-pituitary-thyroid function and control. Thyroid. 2000;10(3):229–234.
   PubMed Web of Science ®Google Scholar
• van Wassenaer AG, Kok JH. Hypothyroxinaemia and thyroid function after preterm birth. Semin Neonatol. 2004;9(1):3–11.
   PubMedGoogle Scholar
• Woo HC, Lizarda A, Tucker R, et al. Congenital hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes. J Pediatr. 2011;158(4):538–542.
   PubMed Web of Science ®Google Scholar
• La Gamma EF, Paneth N. Clinical importance of hypothyroxinemia in the preterm infant and a discussion of treatment concerns. Curr Opin Pediatr. 2012;24(2):172–180.
   PubMed Web of Science ®Google Scholar
• Ogilvy-Stuart AL. Neonatal thyroid disorders. Arch Dis Child Fetal Neonatal Ed. 2002;87(3):F165–F171.
   PubMed Web of Science ®Google Scholar
• Williams FL, Ogston SA, van Toor H, et al. Serum thyroid hormones in preterm infants: associations with postnatal illnesses and drug usage. J Clin Endocrinol Metab. 2005;90(11):5954–5963.
   PubMed Web of Science ®Google Scholar
• Fisher DA. Hypothyroxinemia in premature infants: is thyroxine treatment necessary? Thyroid. 1999;9(7):715–720.
   PubMed Web of Science ®Google Scholar
• Bernal J, Nunez J. Thyroid hormones and brain development. Eur J Endocrinol. 1995;133(4):390–398.
   PubMed Web of Science ®Google Scholar
• Karna P. Developmental follow-up of very low birthweight premature infants with low free thyroxine. Am J Perinatol. 1991;8(4):288–291.
   PubMed Web of Science ®Google Scholar
• Dilli D, Eras Z, Andiran N, et al. Neurodevelopmental evaluation of very low birth weight infants with transient hypothyroxinemia at corrected age of 18–24 months. Indian Pediatr. 2012;49(9):711–715.
   PubMed Web of Science ®Google Scholar
• Chung ML, Yoo HW, Kim KS, et al. Thyroid dysfunctions of prematurity and their impacts on neurodevelopmental outcome. J Pediatr Endocrinol Metab. 2013;26(5–6):449–455.
   PubMed Web of Science ®Google Scholar
• Scratch SE, Hunt RW, Thompson DK, et al. Free thyroxine levels after very preterm birth and neurodevelopmental outcomes at age 7 years. Pediatrics. 2014;133(4):e955–e963.
   PubMed Web of Science ®Google Scholar
• Hollanders JJ, Israëls J, van der Pal SM, et al. No association between transient hypothyroxinemia of prematurity and neurodevelopmental outcome in young adulthood. J Clin Endocrinol Metab. 2015;100(12):4648–4653.
   PubMed Web of Science ®Google Scholar
• Marsh TD, Freeman D, McKeown RE, et al. Increased mortality in neonates with low thyroxine values. J Perinatol. 1993;13(3):201–204.
   PubMedGoogle Scholar
• Paul DA, Leef KH, Stefano JL, et al. Low serum thyroxine on initial newborn screening is associated with intraventricular hemorrhage and death in very low birth weight infants. Pediatrics. 1998;101(5):903–907.
   PubMed Web of Science ®Google Scholar
• Hadeed AJ, Asay LD, Klein AH, et al. Significance of transient postnatal hypothyroxinemia in premature infants with and without respiratory distress syndrome. Pediatrics. 1981;68(4):494–498.
   PubMed Web of Science ®Google Scholar
• Leviton A, Paneth N, Reuss ML, et al. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. J Pediatr. 1999;134(6):706–711.
   PubMed Web of Science ®Google Scholar
• Chowdhry P, Scanlon JW, Auerbach R, et al. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia. Pediatrics. 1984;73(3):301–305.
   PubMed Web of Science ®Google Scholar
• Vanhole C, Aerssens P, Naulaers G, et al. L-thyroxine treatment of preterm newborns: clinical and endocrine effects. Pediatr Res. 1997;42(1):87–92.
   PubMed Web of Science ®Google Scholar
• van Wassenaer-Leemhuis A, Ares S, Golombek S, et al. Thyroid hormone supplementation in preterm infants born before 28 weeks gestational age and neurodevelopmental outcome at age 36 months. Thyroid. 2014;24(7):1162–1169.
   PubMed Web of Science ®Google Scholar
• Uchiyama A, Kushima R, Watanabe T, et al. Effect of L-thyroxine supplementation on very low birth weight infants with transient hypothyroxinemia of prematurity at 3 years of age. J Perinatol. 2017;37(5):602–605.
   PubMed Web of Science ®Google Scholar
• Léger J, Olivieri A, Donaldson M, et al. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. Horm Res Paediatr. 2014;81(2):80–103.
   PubMed Web of Science ®Google Scholar
• Ng SM, Turner MA, Gamble C, et al. An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks’ gestation: results of the TIPIT trial. Trials. 2013;14:211.
   PubMed Web of Science ®Google Scholar
• Kawai M, Matsukura T, Mizumoto H, et al. Effect of levothyroxine administration on the thyroid function in infants with transient hypothyroxinemia of prematurity. J Jpn Soc Perin Neon Med. 2008;44:1192–1196 (in Japanese).
   Google Scholar
• Yamamoto A, Kawai M, Iwanaga K, et al. Response to thyrotropin-releasing hormone stimulation tests in preterm infants with transient hypothyroxinemia of prematurity. J Perinatol. 2015;35(9):725–728.
   PubMed Web of Science ®Google Scholar
• Kaptein EM, Beale E, Chan LS. Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J Clin Endocrinol Metab. 2009;94(10):3663–3675.
   PubMed Web of Science ®Google Scholar
• Yagasaki H, Kobayashi K, Nemoto A, et al. Late-onset circulatory dysfunction after thyroid hormone treatment in an extremely low birth weight infant. J Pediatr Endocrinol Metab. 2010;23(1–2):153–158.
   PubMed Web of Science ®Google Scholar
• Okada J, Iwata S, Hirose A, et al. Levothyroxine replacement therapy and refractory hypotension out of transitional period in preterm infants. Clin Endocrinol (Oxf). 2011;74(3):354–364.
   PubMed Web of Science ®Google Scholar
• Kawai M, Kusuda S, Cho K, et al. Nationwide surveillance of circulatory collapse associated with levothyroxine administration in very-low-birthweight infants in Japan. Pediatr Int. 2012;54(2):177–181.
   PubMed Web of Science ®Google Scholar
• Fonseca V, Brown R, Hochhauser D, et al. Acute adrenal crisis precipitated by thyroxine. Br Med J (Clin Res Ed). 1986;292(6529):1185–1186.
   PubMed Web of Science ®Google Scholar
• La Gamma EF, van Wassenaer AG, Ares S, et al. Phase 1 trial of 4 thyroid hormone regimens for transient hypothyroxinemia in neonates of <28 weeks’ gestation. Pediatrics. 2009;124(2):e258–e268.
   PubMed Web of Science ®Google Scholar